Masimo Corp. Company Profile (NASDAQ:MASI)

Analyst Ratings

Consensus Ratings for Masimo Corp. (NASDAQ:MASI) (?)
Ratings Breakdown: 1 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $50.75 (3.48% downside)

Analysts' Ratings History for Masimo Corp. (NASDAQ:MASI)
Show:
DateFirmActionRatingPrice TargetActions
6/1/2016Raymond James Financial Inc.DowngradeStrong-Buy -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016WedbushBoost Price TargetOutperform$51.00 -> $57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016Piper Jaffray Cos.UpgradeNeutral -> Overweight$43.00 -> $52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016Roth CapitalBoost Price TargetBuy$40.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/1/2016BTIG ResearchReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/9/2015Off Wall StreetReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2014Citigroup Inc.Reiterated RatingNeutral$29.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014BMO Capital MarketsLower Price Target$26.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2014 forward)

Earnings

Earnings History for Masimo Corp. (NASDAQ:MASI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/3/2016Q216$0.41$166.02 millionListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/4/2016Q116$0.43$0.53$165.25 million$171.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2016Q415$0.39$0.15$164.25 million$167.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315$0.31$0.36$149.31 million$152.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q215$0.32$0.36$147.93 million$155.73 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q115$0.35$0.41$151.00 million$154.54 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/17/2015Q414$0.37$0.40$159.45 million$161.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2014Q314$0.25$0.27$144.20 million$144.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q214$0.29$0.24$145.76 million$140.92 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2014Q114$0.29$0.30$144.01 million$139.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/13/2014Q413$0.31$0.31$148.25 million$134.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2013Q313$0.26$0.27$132.47 million$131.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2013Q2 2013$0.28$0.30$136.36 million$137.42 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2013Q1 2013$0.28$0.28$134.46 million$135.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/14/2013Q4 2012$0.29$0.26$129.09 million$132.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2012Q312$0.26$0.26$120.99 million$112.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2012$0.28$0.27ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2012$0.28$0.27ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/14/2012$0.23$0.23ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2011$0.27$0.24ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/9/2011$0.28$0.28ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011$0.30$0.30ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/15/2011$0.26$0.29ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Masimo Corp. (NASDAQ:MASI)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$0.40$0.43$0.42
Q2 20164$0.41$0.42$0.41
Q3 20164$0.40$0.40$0.40
Q4 20165$0.46$0.49$0.48
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Masimo Corp. (NASDAQ:MASI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Masimo Corp. (NASDAQ:MASI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/20/2016Rick FishelInsiderSell22,000$53.85$1,184,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/20/2016Sanford FitchDirectorSell3,000$53.48$160,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/30/2016Ramshorst David J VanCAOSell5,000$52.50$262,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2016Joe E KianiCEOSell65,048$50.00$3,252,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2016Joe E KianiCEOSell234,952$50.09$11,768,745.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2016Jon ColemanInsiderSell4,000$50.00$200,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/31/2016Raad Mark DeCFOSell40,000$49.43$1,977,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/25/2016Rick FishelInsiderSell25,000$49.85$1,246,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2016Jon ColemanInsiderSell8,000$47.00$376,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/28/2016Paul JansenEVPSell10,000$44.88$448,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2016Jon ColemanInsiderSell4,000$44.00$176,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/23/2016Yongsam LeeEVPSell96,000$39.96$3,836,160.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/22/2016Yongsam LeeEVPSell32,000$40.06$1,281,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/21/2016Yongsam LeeEVPSell32,000$39.83$1,274,560.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/15/2016Raad Mark DeCFOSell40,000$39.00$1,560,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Raad Mark DeCFOSell40,000$38.11$1,524,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/24/2015Jon ColemaninsiderSell10,000$42.00$420,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2015Sanford FitchDirectorSell2,000$41.00$82,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2015Sanford FitchDirectorSell2,000$42.67$85,340.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2015Anand SampathCOOSell45,000$42.00$1,890,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2015Jon ColemaninsiderSell10,000$42.38$423,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/14/2015Sanford FitchDirectorSell2,000$39.29$78,580.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2015Paul JansenEVPSell10,000$42.88$428,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2015Sanford FitchDirectorSell2,000$41.29$82,580.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/31/2015Thomas Samuel McclenahanEVPSell22,000$40.62$893,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2015Paul JansenEVPSell10,000$40.88$408,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2015Rick FishelInsiderSell35,084$41.85$1,468,265.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/21/2015Joe E KianiCEOSell300,000$40.55$12,165,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/21/2015Steven BarkerDirectorSell20,000$40.00$800,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/8/2015Sanford FitchDirectorSell2,000$38.18$76,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2015Sanford FitchDirectorSell2,000$36.49$72,980.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2015Steven BarkerDirectorSell25,000$36.20$905,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2015Sanford FitchDirectorSell2,000$34.57$69,140.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2015Rick FishelInsiderSell18,170$29.85$542,374.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2013Robert ColemanDirectorSell59,400$21.93$1,302,642.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Masimo Corp. (NASDAQ:MASI)
DateHeadline
07/28/16 08:15 AMRespiratory Measurement Devices Market size in terms of volume and value 2015-2025
07/28/16 07:18 AMLeading Ohio Critical Access Hospital Adopts Masimo Root® with Radius-7®, Radical-7®, and Patient SafetyNet™ to Create Hospital-Wide Wireless Monitoring and Clinician Notification System - [at noodls] - http://www.businesswire.com/news/home/20160728005606/en/ Masimo Patient SafetyNet is a supplemental system that enables information from bedside and tetherless wearable monitors to be accessible from remote ...
07/26/16 08:07 AMResearch report explores the 2022 newborn screening market
07/25/16 05:11 PMGlobal Carbon Dioxide (CO2) Monitor Industry
07/24/16 09:23 AMPrice Target of $52.5 Set For Masimo Corporation (NASDAQ:MASI) - RealistInvestor.com
07/23/16 09:01 AMMedical device company sets up shop in San Luis Rio Colorado
07/22/16 08:02 AMInvestor News: Masimo Corporation (NASDAQ:MASI) under Investigation concerning potential Violations of Securities Laws
07/21/16 05:19 PMGlobal mHealth Market 2016: Industry Study, Insights, Statistics and Research to 2020
07/21/16 07:55 AMMasimo Corporation (NASDAQ:MASI): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/21/16 07:55 AMMasimo Corporation (NASDAQ:MASI) Analyst Rating Update - Investor Newswire
07/21/16 07:03 AMNew Study Evaluates Masimo PVI® as a Predictor of Fluid Responsiveness in Patients Undergoing Liver Transplantation - [Business Wire] - Masimo announced today that a new study of patients undergoing liver transplantation evaluated the relationship of PVI® to right ventricular end-diastolic volume and concluded that PVI provided a “reliable estimate of preload status and may be a useful predictor of fluid responsiveness.”1 PVI measures the dynamic changes in perfusion index that occur during one or more complete respiratory ...
07/20/16 08:01 AMAccounts Payable For Masimo Corporation (NASDAQ:MASI) Stood At $25.31 - RealistInvestor.com
07/20/16 08:01 AMMasimo Reaches Analyst Target Price - Nasdaq
07/20/16 08:01 AMShares Positive Over the Past Month: Masimo Corporation (NASDAQ:MASI) - TGP
07/20/16 08:01 AMMasimo Corporation Realized Volatility Hits Extremely Low Level - CML News
07/20/16 08:00 AMMasimo to Report Second Quarter 2016 Financial Results after Market Close on Wednesday, August 3 - [Business Wire] - Masimo announced today that it will release financial results for the second quarter ended July 2, 2016, after the market closes on Wednesday, August 3, 2016. The conference call to review the results will begin at 1:30 p.m.
07/20/16 07:30 AMStrength Seen in Dexcom (DXCM) Soars: Stock Soars 6.2% -
07/19/16 11:10 AMMasimo Reaches Analyst Target Price
07/18/16 05:12 PMMASIMO CORP : Entry into a Material Definitive Agreement (form 8-K)
07/18/16 03:39 PMMASIMO CORP Files SEC form 8-K, Entry into a Material Definitive Agreement -
07/17/16 04:33 PMShare Performance Summary for: Masimo Corporation (NASDAQ:MASI) - Press Telegraph
07/17/16 04:33 PMMasimo Corporation (NASDAQ:MASI)'s Growth Projection - RealistInvestor.com
07/17/16 04:33 PMMasimo Corporation (MASI) Hits New 52-week High During July 14 Session - Equities.com
07/16/16 04:45 PMMasimo : C02 PUMP FOR CAPNOSTREAM 20P (MASIMO) (2nd Posting)
07/15/16 09:25 AMMasimo Corporation (NASDAQ:MASI) Short Interest Decreased By 11.64% - Consumer Eagle
07/14/16 05:21 PMNew Lifetime High Today: Masimo (MASI) - TheStreet.com
07/14/16 05:21 PMIs Masimo Corporation a Buy? The Stock Reaches All-Time High Today - Consumer Eagle
07/14/16 05:21 PMShares Seeking a Recent High: Masimo Corporation (NASDAQ:MASI) - Press Telegraph
07/14/16 05:21 PMMasimo Corp. (MASI) Announces Positive Results from New Pronto Pulse CO-Oximeter Study in Pediatric Trauma ... - StreetInsider.com
07/14/16 04:14 PMAngioDynamics (ANGO) Tops Q4 Earnings, '17 View Positive -
07/14/16 07:38 AMNew Study Assesses Utility of 1st Generation Masimo Pronto® Pulse CO-Oximeter® with SpHb® Spot Check Technology in Evaluating Pediatric Trauma Patients - [at noodls] - IRVINE, Calif.--(BUSINESS WIRE)--Jul. 14, 2016-- Masimo (NASDAQ: MASI) announced today that in a new study using the 1 Generation Masimo Pronto Pulse CO-Oximeter, which noninvasively measures total hemoglobin ...
07/14/16 07:04 AM8:04 am Masimo announces results of a new study using the 1st Generation Masimo Pronto Pulse CO-Oximeter, which measures total hemoglobin, results published in the Journal of Trauma & Acute Care Surgery -
07/13/16 05:26 PMMasimo Corporation (NASDAQ:MASI) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/13/16 08:00 AMWere Analysts Bullish Masimo Corporation (NASDAQ:MASI) This Week? - Consumer Eagle
07/12/16 05:18 PMTCPA FCC Petitions Tracker
07/09/16 04:38 PMMasimo Corporation (NASDAQ:MASI) Awarded Price Target of $52.5 - RealistInvestor.com
07/09/16 08:26 AMMasimo Corporation versus Wright Medical Group NV Head to Head Compare - CML News
07/09/16 08:26 AMMasimo Corporation (NASDAQ:MASI) Receives Update on Growth Forecast - RealistInvestor.com
07/08/16 07:57 AMRespiratory Care Devices Market : Growth, Development, and Outlook 2021
07/08/16 07:57 AMNanobubbles generated by pulsed laser identify and destroy cancer cells (w/video)
07/08/16 07:57 AMNIH Researchers Develop Technology Which Assists in Identification and Destruction of Cancer Cells
07/07/16 05:06 PMAntibody-Coated Gold Nanoparticles Accurately Destroy Recurrent Tumors
07/07/16 05:06 PMCerebral and tissue oximetry devices market to grow at 6.92% CAGR to 2020
07/07/16 03:31 PMTrovaGene Inks Partnership with University of Michigan -
07/07/16 07:58 AMInnovative nanobubble treatment finds and destroys cancer cells in mice
07/07/16 07:21 AMOne of the World’s Leading Centers for Cardiovascular Medicine & Transplantation Adopts Masimo’s SedLine® Brain Function Monitoring and O3™ Regional Oximetry - [at noodls] - http://www.businesswire.com/news/home/20160707005661/en/ 'Our non-profit hospital performs over 32,000 treatments each year. Easy access to advanced parameters and the data they provide are very important ...
07/05/16 09:39 AMResearch details developments in the global mHealth market 2016: industry analysis, market size, share, growth and forecast 2020
07/03/16 04:35 PMSt. Paul nonprofit on a global quest to save newborns
07/02/16 07:54 AMInvestor Investigation over Possible Securities Laws Violations by Masimo Corporation (NASDAQ:MASI)
07/01/16 05:02 PMReasons for Ramshorst Van's Shares Sale of Masimo Corporation (NASDAQ:MASI)'s Stock - Press Telegraph

Social

About Masimo Corp.

Masimo Corp. logoMasimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company's business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring. The Company has developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor and the Radius-7 wearable wireless patient monitor. It has also developed the Patient SafetyNet remote patient surveillance monitoring system, which allows over 200 patients to be monitored simultaneously and remotely through a personal computer (PC)-based viewing station or by care providers through their voice-over-Internet Protocol (IP) phones.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: MASI
  • CUSIP: 57479510
Key Metrics:
  • Previous Close: $52.23
  • 50 Day Moving Average: $51.95
  • 200 Day Moving Average: $43.91
  • P/E Ratio: 30.78
  • P/E Growth: 1.90
  • Market Cap: $2.56B
  • Beta: 0.91
  • Current Year EPS Consensus Estimate: $1.83 EPS
  • Next Year EPS Consensus Estimate: $2.04 EPS
Additional Links:
Masimo Corp. (NASDAQ:MASI) Chart for Thursday, July, 28, 2016